Gilead Sciences
GILD
#131
Rank
ยฃ122.12 B
Marketcap
ยฃ98.36
Share price
4.21%
Change (1 day)
20.17%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of March 2026 : ยฃ17.55 Billion

According to Gilead Sciences's latest financial reports the company has ยฃ17.55 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ16.79 B9.51%
2024-12-31$ยฃ15.33 B-14.11%
2023-12-31$ยฃ17.85 B1.86%
2022-12-31$ยฃ17.53 B12.34%
2021-12-31$ยฃ15.60 B16.74%
2020-12-31$ยฃ13.36 B-22.61%
2019-12-31$ยฃ17.27 B1.82%
2018-12-31$ยฃ16.96 B11.84%
2017-12-31$ยฃ15.16 B-3.34%
2016-12-31$ยฃ15.69 B21.67%
2015-12-31$ยฃ12.89 B26.94%
2014-12-31$ยฃ10.16 B42.7%
2013-12-31$ยฃ7.12 B20.59%
2012-12-31$ยฃ5.90 B33.64%
2011-12-31$ยฃ4.41 B11.41%
2010-12-31$ยฃ3.96 B-1.35%
2009-12-31$ยฃ4.01 B31.94%
2008-12-31$ยฃ3.04 B68.13%
2007-12-31$ยฃ1.81 B89.95%
2006-12-31$ยฃ0.95 B-45.66%
2005-12-31$ยฃ1.75 B80.17%
2004-12-31$ยฃ0.97 B73.81%
2003-12-31$ยฃ0.56 B57.35%
2002-12-31$ยฃ0.35 B14.19%
2001-12-31$ยฃ0.31 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ60.83 B 246.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ67.74 B 285.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-ยฃ4.96 Billion-128.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.37 B 33.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.88 B-60.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ13.97 B-20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ2.00 B-88.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ14.50 B-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ34.41 B 96.03%๐Ÿ‡บ๐Ÿ‡ธ USA